Ilya Pharma strengthens board with appointments of corporate development specialist Hughes Crameri and Galderma veteran Carson
Uppsala, May 3, 2022: Ilya Pharma (the Company), a clinical stage immunotherapy company today announced the appointments of Dr Melya Hughes Crameri and William (Bill) Carson to the Board of Directors. The appointments come as the company approaches key stages in the development of its portfolio of three first-in-class immunotherapies for skin and mucosal diseases - ILP100-Topical for treatment of surgical wounds in diabetic, pre-diabetic and obese patients especially at risk, ILP100-Topical for diabetic ulcers and ILP100-Oral for patients with immune mediated enterocolitis resulting from